# The Effects of Hydroxychloroquine in Patients with Inflammatory Cardiomyopathy

> **NCT05961202** · PHASE2,PHASE3 · RECRUITING · sponsor: **Tongji Hospital** · enrollment: 200 (estimated)

## Conditions studied

- Inflammatory Cardiomyopathy
- Myocarditis

## Interventions

- **DRUG:** Hydroxychloroquine
- **DRUG:** Prednisolone

## Key facts

- **NCT ID:** NCT05961202
- **Lead sponsor:** Tongji Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2021-11-01
- **Primary completion:** 2024-09-01
- **Final completion:** 2025-11-01
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2024-10-09

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05961202

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05961202, "The Effects of Hydroxychloroquine in Patients with Inflammatory Cardiomyopathy". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05961202. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*